Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nevis Brands Inc PSCBF


Primary Symbol: C.NEVI

Consumer Defensive Household & Personal Products
Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience... see more

Recent & Breaking News (CSE:NEVI)

InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Cancer Institute Grant for its Acute Lymphoblastic Leukemia Program - Video Available on Investmentpitch.com

Newsfile June 9, 2021

Pascal Biosciences Awarded NIH Grant For Leukemia Program

Accesswire June 8, 2021

Pascal Biosciences Announces New OTC Markets Trading Symbol PSCBF

Accesswire June 2, 2021

Pascal Biosciences Announces Management Changes

Accesswire March 22, 2021

Pascal Biosciences Inc. Closes Second Tranche of Non-Brokered Private Placement of $750,000

Accesswire March 17, 2021

Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit

Accesswire January 21, 2021

Pascal Biosciences and S?RSE Technology Optimize Cannabinoid Formulation for Clinical Development of Cancer Treatment

Accesswire December 8, 2020

Pascal Biosciences Appoints Mark van der Horst as Vice President of Corporate Communications

Accesswire November 10, 2020

Pascal Biosciences Confirms Specific Cannabinoids Combat Coronavirus

Accesswire September 23, 2020

Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceutical Summit

Accesswire September 16, 2020

Pascal Biosciences and S?RSE Technology Announce Partnership for Cannabinoid Drug Development and Cancer Clinical Trials

Accesswire September 14, 2020

Pascal Biosciences Announces Listing on the Frankfurt Stock Exchange

Accesswire August 4, 2020

Pascal Biosciences Announces Feature Article

Accesswire July 17, 2020

Pascal Biosciences Discovers a Cannabinoid That Combats Coronavirus

Accesswire July 14, 2020

Pascal Biosciences Appoints Dr. Michael Shepard to Board of Directors

Accesswire July 9, 2020

S?RSE Technology Partners with & Acquires Part of Cancer Research Group Pascal Biosciences for Cannabinoid Research Programs

Business Wire March 11, 2020

Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia

GlobeNewswire October 29, 2019

Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment

GlobeNewswire September 23, 2019

Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceuticals Summit

GlobeNewswire September 11, 2019

Pascal Biosciences to Present at 2019 BIO International Convention

GlobeNewswire May 29, 2019